Abstract
Following fertilization, totipotent cells undergo asymmetric cell divisions, resulting in three distinct cell types in the late pre-implantation blastocyst: epiblast (Epi), primitive endoderm (PrE), and trophectoderm (TE). Here, we aim to understand whether these three cell types can be induced from fibroblasts by one combination of transcription factors. By utilizing a sophisticated fluorescent knockin reporter system, we identified a combination of five transcription factors, Gata3, Eomes, Tfap2c, Myc, and Esrrb, that can reprogram fibroblasts into induced pluripotent stem cells (iPSCs), induced trophoblast stem cells (iTSCs), and induced extraembryonic endoderm stem cells (iXENs), concomitantly. In-depth transcriptomic, chromatin, and epigenetic analyses provide insights into the molecular mechanisms that underlie the reprogramming process toward the three cell types. Mechanistically, we show that the interplay between Esrrb and Eomes during the reprogramming process determines cell fate, where high levels of Esrrb induce a XEN-like state that drives pluripotency and high levels of Eomes drive trophectodermal fate. Benchetrit and colleagues identified a combination of factors that can produce the three in vitro equivalent cell types of the blastocyst, iPSCs, iTSCs, and iXENs, from fibroblasts. They found that Esrrb was most potent in inducing pluripotency by the activation of a XEN-like state and Eomes most potent in promoting trophectoderm fate.
Original language | American English |
---|---|
Pages (from-to) | 983-994.e7 |
Journal | Cell Stem Cell |
Volume | 24 |
Issue number | 6 |
DOIs | |
State | Published - 6 Jun 2019 |
Bibliographical note
Funding Information:Y.B. is supported by the European Research Council (ERC) (no. 676843), the Israeli Center of Research Excellence (I-CORE) program (center no. 41/11), the Israel Science Foundation (ISF) (no. 823/14), EMBO Young Investigator Programme (YIP), DKFZ-MOST (CA 177), and Howard Hughes Medical Institute (HHMI) (no. 55008727). A.R. is supported by BIRAX (030-5187). T.K. is supported by I-CORE program (centers no. 41/11 and no. 1796/12) and ISF, no. 913/15. Y.B. conceived the study, wrote the manuscript, and prepared the figures. H.B. M.J. and Y.B. designed the experiments. H.B. and M.J. performed cloning, reprogramming, infection, iTSC and iPSC isolation, FACS, ChIP-qPCR, RNA preparation, and immunostaining. S.S. generated RNA and ATAC libraries. T.K. analyzed all RNA-seq, ATAC-seq, and ChIP-seq data. M.J. and O.R. performed ChIP-seq. Y.B. and V.Z. built the BYKE system. K.M. performed iTSC and iPSC injections. N.M. validated Esrrb KD. N.R. cloned factors. Z.Z. characterized GETMS-iXENs. A.R. analyzed the XEN-like signature. A.P. and H.B. performed the experiments with ZHBTc4. M.I. analyzed some of the ChIP-seq and RNA-seq data. The authors declare no competing interests.
Funding Information:
Y.B. is supported by the European Research Council (ERC) (no. 676843 ), the Israeli Center of Research Excellence (I-CORE) program (center no. 41/11 ), the Israel Science Foundation (ISF) (no. 823/14 ), EMBO Young Investigator Programme (YIP), DKFZ-MOST ( CA 177 ), and Howard Hughes Medical Institute (HHMI) (no. 55008727 ). A.R. is supported by BIRAX ( 030-5187 ). T.K. is supported by I-CORE program (centers no. 41/11 and no. 1796/12 ) and ISF , no. 913/15 .
Publisher Copyright:
© 2019 The Author(s)
Keywords
- Eomes
- Esrrb
- early embryonic development
- induced extraembryonic endoderm stem cells
- induced pluripotent stem cells
- induced trophoblast stem cells
- inner cell mass
- primitive endoderm
- reprogramming
- trophectoderm